Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization

Marcus D. Ruopp, Tara C. Collins, Brian W. Whitcomb, Enrique F. Schisterman

Research output: Contribution to journalArticle

Abstract

Objective: To assess the conflicting evidence whether low-dose aspirin is beneficial in IVF and to evaluate the meta-analysis performed by Gelbaya et al. and reported in March 2007 in Human Reproduction Update, in which they found no effects of low-dose aspirin and recommended discontinuing its use in IVF. We present a reanalysis of the effects of low-dose aspirin in IVF and raise methodological questions regarding the analysis by Gelbaya et al. Design: A meta-analysis of prospective randomized trials evaluating the effects of low-dose aspirin in IVF. Patient(s): Women undergoing IVF/intracytoplasmic sperm injection. Intervention(s): Low-dose acetylsalicylic acid (aspirin). Main Outcome Measure(s): Pregnancy rates, implantation rates, miscarriage rates. Result(s): Ten randomized clinical trials were included in the analysis. Clinical pregnancy rate per ET was significant when low-dose aspirin was compared with no treatment (risk ratio 1.15, 95% confidence interval 1.03-1.27). Nonsignificant estimates comparing low-dose aspirin with no treatment were found for implantation and miscarriage rates. Conclusion(s): Our results suggest that aspirin may increase clinical pregnancy rates and that more data are needed to resolve the issue. At this point, there is no reason to change clinical management and discontinue the use of aspirin.

Original languageEnglish (US)
Pages (from-to)71-76
Number of pages6
JournalFertility and Sterility
Volume90
Issue number1
DOIs
StatePublished - Jul 2008
Externally publishedYes

Fingerprint

Fertilization in Vitro
Aspirin
Pregnancy Rate
Spontaneous Abortion
Meta-Analysis
Intracytoplasmic Sperm Injections
Reproduction
Randomized Controlled Trials
Odds Ratio
Outcome Assessment (Health Care)
Confidence Intervals

Keywords

  • Aspirin
  • fixed-effects
  • implantation
  • in vitro fertilization
  • pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization. / Ruopp, Marcus D.; Collins, Tara C.; Whitcomb, Brian W.; Schisterman, Enrique F.

In: Fertility and Sterility, Vol. 90, No. 1, 07.2008, p. 71-76.

Research output: Contribution to journalArticle

Ruopp, Marcus D. ; Collins, Tara C. ; Whitcomb, Brian W. ; Schisterman, Enrique F. / Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization. In: Fertility and Sterility. 2008 ; Vol. 90, No. 1. pp. 71-76.
@article{a9075bdaf1354f41b1d4928a813320ba,
title = "Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization",
abstract = "Objective: To assess the conflicting evidence whether low-dose aspirin is beneficial in IVF and to evaluate the meta-analysis performed by Gelbaya et al. and reported in March 2007 in Human Reproduction Update, in which they found no effects of low-dose aspirin and recommended discontinuing its use in IVF. We present a reanalysis of the effects of low-dose aspirin in IVF and raise methodological questions regarding the analysis by Gelbaya et al. Design: A meta-analysis of prospective randomized trials evaluating the effects of low-dose aspirin in IVF. Patient(s): Women undergoing IVF/intracytoplasmic sperm injection. Intervention(s): Low-dose acetylsalicylic acid (aspirin). Main Outcome Measure(s): Pregnancy rates, implantation rates, miscarriage rates. Result(s): Ten randomized clinical trials were included in the analysis. Clinical pregnancy rate per ET was significant when low-dose aspirin was compared with no treatment (risk ratio 1.15, 95{\%} confidence interval 1.03-1.27). Nonsignificant estimates comparing low-dose aspirin with no treatment were found for implantation and miscarriage rates. Conclusion(s): Our results suggest that aspirin may increase clinical pregnancy rates and that more data are needed to resolve the issue. At this point, there is no reason to change clinical management and discontinue the use of aspirin.",
keywords = "Aspirin, fixed-effects, implantation, in vitro fertilization, pregnancy",
author = "Ruopp, {Marcus D.} and Collins, {Tara C.} and Whitcomb, {Brian W.} and Schisterman, {Enrique F.}",
year = "2008",
month = "7",
doi = "10.1016/j.fertnstert.2007.06.033",
language = "English (US)",
volume = "90",
pages = "71--76",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization

AU - Ruopp, Marcus D.

AU - Collins, Tara C.

AU - Whitcomb, Brian W.

AU - Schisterman, Enrique F.

PY - 2008/7

Y1 - 2008/7

N2 - Objective: To assess the conflicting evidence whether low-dose aspirin is beneficial in IVF and to evaluate the meta-analysis performed by Gelbaya et al. and reported in March 2007 in Human Reproduction Update, in which they found no effects of low-dose aspirin and recommended discontinuing its use in IVF. We present a reanalysis of the effects of low-dose aspirin in IVF and raise methodological questions regarding the analysis by Gelbaya et al. Design: A meta-analysis of prospective randomized trials evaluating the effects of low-dose aspirin in IVF. Patient(s): Women undergoing IVF/intracytoplasmic sperm injection. Intervention(s): Low-dose acetylsalicylic acid (aspirin). Main Outcome Measure(s): Pregnancy rates, implantation rates, miscarriage rates. Result(s): Ten randomized clinical trials were included in the analysis. Clinical pregnancy rate per ET was significant when low-dose aspirin was compared with no treatment (risk ratio 1.15, 95% confidence interval 1.03-1.27). Nonsignificant estimates comparing low-dose aspirin with no treatment were found for implantation and miscarriage rates. Conclusion(s): Our results suggest that aspirin may increase clinical pregnancy rates and that more data are needed to resolve the issue. At this point, there is no reason to change clinical management and discontinue the use of aspirin.

AB - Objective: To assess the conflicting evidence whether low-dose aspirin is beneficial in IVF and to evaluate the meta-analysis performed by Gelbaya et al. and reported in March 2007 in Human Reproduction Update, in which they found no effects of low-dose aspirin and recommended discontinuing its use in IVF. We present a reanalysis of the effects of low-dose aspirin in IVF and raise methodological questions regarding the analysis by Gelbaya et al. Design: A meta-analysis of prospective randomized trials evaluating the effects of low-dose aspirin in IVF. Patient(s): Women undergoing IVF/intracytoplasmic sperm injection. Intervention(s): Low-dose acetylsalicylic acid (aspirin). Main Outcome Measure(s): Pregnancy rates, implantation rates, miscarriage rates. Result(s): Ten randomized clinical trials were included in the analysis. Clinical pregnancy rate per ET was significant when low-dose aspirin was compared with no treatment (risk ratio 1.15, 95% confidence interval 1.03-1.27). Nonsignificant estimates comparing low-dose aspirin with no treatment were found for implantation and miscarriage rates. Conclusion(s): Our results suggest that aspirin may increase clinical pregnancy rates and that more data are needed to resolve the issue. At this point, there is no reason to change clinical management and discontinue the use of aspirin.

KW - Aspirin

KW - fixed-effects

KW - implantation

KW - in vitro fertilization

KW - pregnancy

UR - http://www.scopus.com/inward/record.url?scp=45949091879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45949091879&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2007.06.033

DO - 10.1016/j.fertnstert.2007.06.033

M3 - Article

C2 - 17889863

AN - SCOPUS:45949091879

VL - 90

SP - 71

EP - 76

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 1

ER -